Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of interleukin-12 production (GO:0032695) | 5.33820747 |
2 | positive regulation by symbiont of host defense response (GO:0052509) | 4.69431146 |
3 | modulation by symbiont of host defense response (GO:0052031) | 4.69431146 |
4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.69431146 |
5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.69431146 |
6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.69431146 |
7 | modulation by symbiont of host immune response (GO:0052553) | 4.69431146 |
8 | adhesion of symbiont to host cell (GO:0044650) | 3.98568922 |
9 | virion attachment to host cell (GO:0019062) | 3.98568922 |
10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.96334347 |
11 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.91831550 |
12 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.83554161 |
13 | immunoglobulin mediated immune response (GO:0016064) | 3.80544973 |
14 | detection of molecule of bacterial origin (GO:0032490) | 3.80436147 |
15 | angiotensin maturation (GO:0002003) | 3.79012761 |
16 | detection of other organism (GO:0098543) | 3.73738857 |
17 | cellular extravasation (GO:0045123) | 3.73110358 |
18 | macrophage activation involved in immune response (GO:0002281) | 3.60382627 |
19 | T-helper 1 type immune response (GO:0042088) | 3.60061540 |
20 | germinal center formation (GO:0002467) | 3.54990851 |
21 | regulation of gamma-delta T cell activation (GO:0046643) | 3.47407951 |
22 | detection of bacterium (GO:0016045) | 3.45661458 |
23 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.42059102 |
24 | detection of external biotic stimulus (GO:0098581) | 3.40487527 |
25 | defense response to protozoan (GO:0042832) | 3.36016912 |
26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.34887439 |
27 | lipoprotein transport (GO:0042953) | 3.31806132 |
28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.27726319 |
29 | response to muramyl dipeptide (GO:0032495) | 3.26761860 |
30 | neutrophil activation involved in immune response (GO:0002283) | 3.23774115 |
31 | response to protozoan (GO:0001562) | 3.23686938 |
32 | NIK/NF-kappaB signaling (GO:0038061) | 3.23537245 |
33 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.22083954 |
34 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.21139995 |
35 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.18921213 |
36 | adhesion of symbiont to host (GO:0044406) | 3.18658266 |
37 | regulation of mast cell activation (GO:0033003) | 3.17820825 |
38 | response to lipoprotein particle (GO:0055094) | 3.14375307 |
39 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.14079496 |
40 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.13063224 |
41 | positive regulation of p38MAPK cascade (GO:1900745) | 3.12064470 |
42 | leukocyte aggregation (GO:0070486) | 3.10840950 |
43 | macroautophagy (GO:0016236) | 3.09685828 |
44 | regulation of antigen processing and presentation (GO:0002577) | 3.09417867 |
45 | detection of biotic stimulus (GO:0009595) | 3.08176397 |
46 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.08158694 |
47 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.07856789 |
48 | type I interferon signaling pathway (GO:0060337) | 3.06456897 |
49 | cellular response to type I interferon (GO:0071357) | 3.06456897 |
50 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.05962404 |
51 | response to type I interferon (GO:0034340) | 3.05144256 |
52 | positive regulation of type 2 immune response (GO:0002830) | 3.04640398 |
53 | negative regulation of cell killing (GO:0031342) | 3.04293360 |
54 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.04293360 |
55 | positive regulation of mast cell degranulation (GO:0043306) | 3.02573070 |
56 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.02573070 |
57 | response to host immune response (GO:0052572) | 3.02144136 |
58 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.02144136 |
59 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.00750535 |
60 | regulation of T cell tolerance induction (GO:0002664) | 3.00517316 |
61 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.96184323 |
62 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.95206379 |
63 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.93344971 |
64 | regulation of interleukin-12 production (GO:0032655) | 2.91699140 |
65 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.91294217 |
66 | intestinal absorption (GO:0050892) | 2.90330002 |
67 | negative regulation of T cell mediated immunity (GO:0002710) | 2.89767582 |
68 | regulation of tolerance induction (GO:0002643) | 2.89483172 |
69 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.87134510 |
70 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.86544828 |
71 | regulation of mononuclear cell migration (GO:0071675) | 2.84982762 |
72 | intestinal cholesterol absorption (GO:0030299) | 2.82269494 |
73 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.81621137 |
74 | neutrophil chemotaxis (GO:0030593) | 2.81073300 |
75 | myeloid dendritic cell differentiation (GO:0043011) | 2.78467617 |
76 | positive regulation of heat generation (GO:0031652) | 2.78088653 |
77 | mannose metabolic process (GO:0006013) | 2.77952390 |
78 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.77703056 |
79 | regulation of podosome assembly (GO:0071801) | 2.77286642 |
80 | microglial cell activation (GO:0001774) | 2.74986542 |
81 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.74701812 |
82 | neutrophil migration (GO:1990266) | 2.73988879 |
83 | response to host (GO:0075136) | 2.73735109 |
84 | response to host defenses (GO:0052200) | 2.73735109 |
85 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.73735109 |
86 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.73725944 |
87 | myeloid leukocyte activation (GO:0002274) | 2.73558871 |
88 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.71804727 |
89 | B cell mediated immunity (GO:0019724) | 2.71753534 |
90 | cellular potassium ion homeostasis (GO:0030007) | 2.70780446 |
91 | protein localization to endosome (GO:0036010) | 2.64675157 |
92 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.63866747 |
93 | regulation of ARF protein signal transduction (GO:0032012) | 2.63393691 |
94 | protein kinase C signaling (GO:0070528) | 2.63033105 |
95 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.62529743 |
96 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.61722940 |
97 | peptide hormone processing (GO:0016486) | 2.58390003 |
98 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.55547626 |
99 | L-amino acid import (GO:0043092) | 2.53613229 |
100 | sodium ion export (GO:0071436) | 2.53162328 |
101 | regulation of beta-amyloid formation (GO:1902003) | 2.49875727 |
102 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.47021574 |
103 | macrophage activation (GO:0042116) | 2.44804556 |
104 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.43979846 |
105 | myeloid cell activation involved in immune response (GO:0002275) | 2.42089370 |
106 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.41401738 |
107 | neutrophil mediated immunity (GO:0002446) | 2.38383943 |
108 | potassium ion import (GO:0010107) | 2.38162398 |
109 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.36965623 |
110 | regulation of leukocyte degranulation (GO:0043300) | 2.36076731 |
111 | cytidine deamination (GO:0009972) | 2.35499114 |
112 | cytidine metabolic process (GO:0046087) | 2.35499114 |
113 | cytidine catabolic process (GO:0006216) | 2.35499114 |
114 | apoptotic cell clearance (GO:0043277) | 2.34080428 |
115 | positive regulation of antigen processing and presentation (GO:0002579) | 2.33117101 |
116 | respiratory burst (GO:0045730) | 2.31719809 |
117 | I-kappaB phosphorylation (GO:0007252) | 2.30583149 |
118 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.28792523 |
119 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.28095010 |
120 | glycosylceramide metabolic process (GO:0006677) | 2.27852701 |
121 | neutrophil activation (GO:0042119) | 2.27732112 |
122 | regulation of p38MAPK cascade (GO:1900744) | 2.27275229 |
123 | regulation of regulated secretory pathway (GO:1903305) | 2.26775480 |
124 | regulation of cellular amide metabolic process (GO:0034248) | 2.25696570 |
125 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.25259168 |
126 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.23671160 |
127 | granulocyte activation (GO:0036230) | 2.20417302 |
128 | positive regulation of interferon-alpha production (GO:0032727) | 2.18434620 |
129 | positive regulation of leukocyte degranulation (GO:0043302) | 2.17206081 |
130 | establishment of protein localization to Golgi (GO:0072600) | 2.16122832 |
131 | protein targeting to Golgi (GO:0000042) | 2.15741315 |
132 | regulation of ARF GTPase activity (GO:0032312) | 2.14504827 |
133 | negative regulation of bone resorption (GO:0045779) | 2.14276305 |
134 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.13414426 |
135 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.13226446 |
136 | nerve growth factor signaling pathway (GO:0038180) | 2.12267759 |
137 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.10402086 |
138 | phagosome maturation (GO:0090382) | 2.09484160 |
139 | regulation of interferon-alpha production (GO:0032647) | 2.09213747 |
140 | regulation of cholesterol storage (GO:0010885) | 2.08895301 |
141 | regulation of mast cell degranulation (GO:0043304) | 2.07948996 |
142 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.06210666 |
143 | peptide catabolic process (GO:0043171) | 2.05928381 |
144 | B cell receptor signaling pathway (GO:0050853) | 2.05845016 |
145 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.05676538 |
146 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.05606128 |
147 | phospholipid translocation (GO:0045332) | 2.05103814 |
148 | lipid translocation (GO:0034204) | 2.05103814 |
149 | amino acid import (GO:0043090) | 2.04745361 |
150 | viral entry into host cell (GO:0046718) | 2.04668227 |
151 | relaxation of cardiac muscle (GO:0055119) | 2.04064262 |
152 | response to peptidoglycan (GO:0032494) | 2.03892589 |
153 | positive regulation of mast cell activation (GO:0033005) | 2.02967591 |
154 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.02188107 |
155 | response to hepatocyte growth factor (GO:0035728) | 2.01632424 |
156 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.01632424 |
157 | negative regulation of interleukin-1 production (GO:0032692) | 2.00687730 |
158 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.00357573 |
159 | Golgi to endosome transport (GO:0006895) | 1.99610785 |
160 | actin filament polymerization (GO:0030041) | 1.98891269 |
161 | negative regulation of interleukin-6 production (GO:0032715) | 1.98573688 |
162 | cortical actin cytoskeleton organization (GO:0030866) | 1.98463337 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.89788984 |
2 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.79528768 |
3 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.72444084 |
4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.70530856 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.47790504 |
6 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.45255230 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.41507284 |
8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.23061256 |
9 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.13047655 |
10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.11693115 |
11 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.08038034 |
12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.01653007 |
13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.00126558 |
14 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.95357851 |
15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.91231066 |
16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.78800301 |
17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.76216955 |
18 | MAF_26560356_Chip-Seq_TH1_Human | 1.73122390 |
19 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.65188756 |
20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.65101064 |
21 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.64325066 |
22 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.62532942 |
23 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55766113 |
24 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.52203166 |
25 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.48204745 |
26 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.46357724 |
27 | UTX_26944678_Chip-Seq_JUKART_Human | 1.46306828 |
28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.45142643 |
29 | MYB_26560356_Chip-Seq_TH2_Human | 1.43684264 |
30 | GATA1_19941826_ChIP-Seq_K562_Human | 1.41586672 |
31 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39975184 |
32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.36847533 |
33 | MYC_22102868_ChIP-Seq_BL_Human | 1.35674048 |
34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.35148309 |
35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.35118588 |
36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.34664790 |
37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.33631655 |
38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32023051 |
39 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.31932973 |
40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30332099 |
41 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29947949 |
42 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29394947 |
43 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.28516659 |
44 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28427691 |
45 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27695744 |
46 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27095185 |
47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26832117 |
48 | MAF_26560356_Chip-Seq_TH2_Human | 1.26808061 |
49 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.26109000 |
50 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25346779 |
51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25181372 |
52 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.24186976 |
53 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23838145 |
54 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23156133 |
55 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22394150 |
56 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21424317 |
57 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21335501 |
58 | GATA2_19941826_ChIP-Seq_K562_Human | 1.20419547 |
59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20224824 |
60 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20118212 |
61 | MYB_26560356_Chip-Seq_TH1_Human | 1.18951775 |
62 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18070075 |
63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17560887 |
64 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16608432 |
65 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16130274 |
66 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.16028078 |
67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15063607 |
68 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.14772329 |
69 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.14365852 |
70 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14022238 |
71 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12821088 |
72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10761209 |
73 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.10438836 |
74 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10102914 |
75 | KDM2B_26808549_Chip-Seq_K562_Human | 1.10064469 |
76 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.09853197 |
77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09744791 |
78 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.09618127 |
79 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.09224452 |
80 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.07470168 |
81 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07020592 |
82 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06915639 |
83 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06637250 |
84 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04905716 |
85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04198610 |
86 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.04137296 |
87 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03584257 |
88 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.03541302 |
89 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03473395 |
90 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.01495287 |
91 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.01193703 |
92 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00384731 |
93 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.99614303 |
94 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.99373415 |
95 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98936573 |
96 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98740447 |
97 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.98705485 |
98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97741863 |
99 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95860139 |
100 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95396130 |
101 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94242545 |
102 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92073133 |
103 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90824595 |
104 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.90506698 |
105 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.89851649 |
106 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87789803 |
107 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87634723 |
108 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.87478639 |
109 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.87334855 |
110 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.85728900 |
111 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.85600532 |
112 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.85599360 |
113 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.85141058 |
114 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.84990556 |
115 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.84885251 |
116 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.84569763 |
117 | * STAT1_20625510_ChIP-Seq_HELA_Human | 0.84324549 |
118 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83722051 |
119 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83524288 |
120 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83408202 |
121 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.82899932 |
122 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.81940276 |
123 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.79933783 |
124 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79811836 |
125 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.79407308 |
126 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.78544203 |
127 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.77834209 |
128 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.77798866 |
129 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76913740 |
130 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.76563305 |
131 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.75563198 |
132 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.75273593 |
133 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75157669 |
134 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.74773828 |
135 | TP53_16413492_ChIP-PET_HCT116_Human | 0.74633731 |
136 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.74377922 |
137 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.73791993 |
138 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.72630246 |
139 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.72430784 |
140 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72416154 |
141 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72416154 |
142 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.72246867 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005058_abnormal_lysosome_morphology | 4.86382776 |
2 | MP0003183_abnormal_peptide_metabolism | 4.69461378 |
3 | MP0000569_abnormal_digit_pigmentation | 3.96113653 |
4 | MP0003172_abnormal_lysosome_physiology | 3.88950731 |
5 | MP0009840_abnormal_foam_cell | 3.16987642 |
6 | MP0003300_gastrointestinal_ulcer | 3.00879136 |
7 | MP0003303_peritoneal_inflammation | 2.70509763 |
8 | MP0004043_abnormal_pH_regulation | 2.42269438 |
9 | MP0003690_abnormal_glial_cell | 2.34606029 |
10 | MP0009764_decreased_sensitivity_to | 2.24912961 |
11 | MP0000604_amyloidosis | 2.14842688 |
12 | MP0005360_urolithiasis | 2.13694988 |
13 | MP0000920_abnormal_myelination | 1.99023602 |
14 | MP0005451_abnormal_body_composition | 1.97439313 |
15 | MP0006082_CNS_inflammation | 1.89048778 |
16 | MP0003191_abnormal_cellular_cholesterol | 1.88299076 |
17 | MP0004510_myositis | 1.86646646 |
18 | MP0002419_abnormal_innate_immunity | 1.85872570 |
19 | MP0001835_abnormal_antigen_presentation | 1.82245754 |
20 | MP0005174_abnormal_tail_pigmentation | 1.82171421 |
21 | MP0009780_abnormal_chondrocyte_physiolo | 1.81694887 |
22 | MP0001790_abnormal_immune_system | 1.80097869 |
23 | MP0005387_immune_system_phenotype | 1.80097869 |
24 | MP0003436_decreased_susceptibility_to | 1.77342453 |
25 | MP0005310_abnormal_salivary_gland | 1.75770750 |
26 | MP0000343_altered_response_to | 1.74661535 |
27 | MP0002909_abnormal_adrenal_gland | 1.67569107 |
28 | MP0001666_abnormal_nutrient_absorption | 1.67470013 |
29 | MP0005000_abnormal_immune_tolerance | 1.55465955 |
30 | MP0010386_abnormal_urinary_bladder | 1.54401932 |
31 | MP0004947_skin_inflammation | 1.52754282 |
32 | MP0003866_abnormal_defecation | 1.49659507 |
33 | MP0005464_abnormal_platelet_physiology | 1.49193671 |
34 | MP0005397_hematopoietic_system_phenotyp | 1.45277226 |
35 | MP0001545_abnormal_hematopoietic_system | 1.45277226 |
36 | MP0000015_abnormal_ear_pigmentation | 1.34333368 |
37 | MP0004270_analgesia | 1.34282986 |
38 | MP0003634_abnormal_glial_cell | 1.34174394 |
39 | MP0002693_abnormal_pancreas_physiology | 1.34172757 |
40 | MP0003075_altered_response_to | 1.33324963 |
41 | MP0002452_abnormal_antigen_presenting | 1.32208837 |
42 | MP0009333_abnormal_splenocyte_physiolog | 1.32149212 |
43 | MP0005167_abnormal_blood-brain_barrier | 1.31708282 |
44 | MP0005025_abnormal_response_to | 1.28769741 |
45 | MP0002139_abnormal_hepatobiliary_system | 1.28497702 |
46 | MP0001853_heart_inflammation | 1.28267019 |
47 | MP0008961_abnormal_basal_metabolism | 1.26160218 |
48 | MP0005257_abnormal_intraocular_pressure | 1.25042512 |
49 | MP0008260_abnormal_autophagy | 1.23982741 |
50 | MP0002723_abnormal_immune_serum | 1.22292802 |
51 | MP0002398_abnormal_bone_marrow | 1.21212489 |
52 | MP0008004_abnormal_stomach_pH | 1.20515671 |
53 | MP0004859_abnormal_synaptic_plasticity | 1.19504443 |
54 | MP0001800_abnormal_humoral_immune | 1.19452650 |
55 | MP0003828_pulmonary_edema | 1.19005307 |
56 | MP0003329_amyloid_beta_deposits | 1.18972026 |
57 | MP0003045_fibrosis | 1.18825432 |
58 | MP0000858_altered_metastatic_potential | 1.18127909 |
59 | MP0003448_altered_tumor_morphology | 1.16403371 |
60 | MP0001533_abnormal_skeleton_physiology | 1.13882046 |
61 | MP0002277_abnormal_respiratory_mucosa | 1.12364088 |
62 | MP0001765_abnormal_ion_homeostasis | 1.11903605 |
63 | MP0000685_abnormal_immune_system | 1.11080463 |
64 | MP0003806_abnormal_nucleotide_metabolis | 1.10926692 |
65 | MP0002148_abnormal_hypersensitivity_rea | 1.10086833 |
66 | MP0001819_abnormal_immune_cell | 1.09470384 |
67 | MP0002420_abnormal_adaptive_immunity | 1.08880647 |
68 | MP0003633_abnormal_nervous_system | 1.07625004 |
69 | MP0000689_abnormal_spleen_morphology | 1.07568073 |
70 | MP0001958_emphysema | 1.07164730 |
71 | MP0002998_abnormal_bone_remodeling | 1.07006805 |
72 | MP0002429_abnormal_blood_cell | 1.06692732 |
73 | MP0003453_abnormal_keratinocyte_physiol | 1.04322341 |
74 | MP0009278_abnormal_bone_marrow | 1.04099832 |
75 | MP0002138_abnormal_hepatobiliary_system | 1.03862084 |
76 | MP0009643_abnormal_urine_homeostasis | 1.03543654 |
77 | MP0003656_abnormal_erythrocyte_physiolo | 1.03257572 |
78 | MP0001845_abnormal_inflammatory_respons | 1.02070716 |
79 | MP0005671_abnormal_response_to | 1.01692754 |
80 | MP0004264_abnormal_extraembryonic_tissu | 1.01262555 |
81 | MP0003879_abnormal_hair_cell | 0.99382853 |
82 | MP0001851_eye_inflammation | 0.99069137 |
83 | MP0006054_spinal_hemorrhage | 0.98673845 |
84 | MP0002722_abnormal_immune_system | 0.98324466 |
85 | MP0002332_abnormal_exercise_endurance | 0.97515558 |
86 | MP0000538_abnormal_urinary_bladder | 0.97254334 |
87 | MP0005164_abnormal_response_to | 0.96830092 |
88 | MP0002229_neurodegeneration | 0.95373596 |
89 | MP0009046_muscle_twitch | 0.93633174 |
90 | MP0004883_abnormal_blood_vessel | 0.92816440 |
91 | MP0004885_abnormal_endolymph | 0.92224087 |
92 | MP0002064_seizures | 0.92212589 |
93 | MP0003763_abnormal_thymus_physiology | 0.92106730 |
94 | MP0003283_abnormal_digestive_organ | 0.91819758 |
95 | MP0008569_lethality_at_weaning | 0.90198965 |
96 | MP0003195_calcinosis | 0.89769603 |
97 | MP0010678_abnormal_skin_adnexa | 0.89204627 |
98 | MP0005166_decreased_susceptibility_to | 0.89146478 |
99 | MP0004742_abnormal_vestibular_system | 0.89081257 |
100 | MP0005409_darkened_coat_color | 0.88927478 |
101 | MP0010155_abnormal_intestine_physiology | 0.85224254 |
102 | MP0005390_skeleton_phenotype | 0.84443210 |
103 | MP0000462_abnormal_digestive_system | 0.83955239 |
104 | MP0008469_abnormal_protein_level | 0.83592035 |
105 | MP0002136_abnormal_kidney_physiology | 0.83304448 |
106 | MP0000383_abnormal_hair_follicle | 0.83165888 |
107 | MP0002254_reproductive_system_inflammat | 0.82258813 |
108 | MP0002405_respiratory_system_inflammati | 0.82178693 |
109 | MP0004858_abnormal_nervous_system | 0.82081537 |
110 | MP0009763_increased_sensitivity_to | 0.81953204 |
111 | MP0003252_abnormal_bile_duct | 0.81467795 |
112 | MP0009785_altered_susceptibility_to | 0.80987967 |
113 | MP0001756_abnormal_urination | 0.80669185 |
114 | MP0009765_abnormal_xenobiotic_induced | 0.80476598 |
115 | MP0002877_abnormal_melanocyte_morpholog | 0.78947469 |
116 | MP0002078_abnormal_glucose_homeostasis | 0.78494624 |
117 | MP0004019_abnormal_vitamin_homeostasis | 0.78283002 |
118 | MP0002090_abnormal_vision | 0.78158325 |
119 | MP0000465_gastrointestinal_hemorrhage | 0.75303320 |
120 | MP0001873_stomach_inflammation | 0.73760009 |
121 | MP0010329_abnormal_lipoprotein_level | 0.73713786 |
122 | MP0000716_abnormal_immune_system | 0.72477965 |
123 | MP0008874_decreased_physiological_sensi | 0.72356101 |
124 | MP0005381_digestive/alimentary_phenotyp | 0.71864015 |
125 | MP0001663_abnormal_digestive_system | 0.71372689 |
126 | MP0003795_abnormal_bone_structure | 0.69217737 |
127 | MP0002118_abnormal_lipid_homeostasis | 0.69206518 |
128 | MP0003724_increased_susceptibility_to | 0.68277598 |
129 | MP0002928_abnormal_bile_duct | 0.67786160 |
130 | MP0003631_nervous_system_phenotype | 0.67757480 |
131 | MP0000003_abnormal_adipose_tissue | 0.67602377 |
132 | MP0002933_joint_inflammation | 0.66889783 |
133 | MP0001849_ear_inflammation | 0.66587277 |
134 | MP0000249_abnormal_blood_vessel | 0.66178717 |
135 | MP0002132_abnormal_respiratory_system | 0.64325226 |
136 | MP0005535_abnormal_body_temperature | 0.62813664 |
137 | MP0001501_abnormal_sleep_pattern | 0.60907738 |
138 | MP0003646_muscle_fatigue | 0.59805623 |
139 | MP0005319_abnormal_enzyme/_coenzyme | 0.58042533 |
140 | MP0000371_diluted_coat_color | 0.57533550 |
141 | MP0005076_abnormal_cell_differentiation | 0.55326540 |
142 | MP0000703_abnormal_thymus_morphology | 0.55067121 |
143 | MP0005647_abnormal_sex_gland | 0.54412985 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Increased cerebral lipofuscin (HP:0011813) | 5.15074508 |
2 | Orchitis (HP:0100796) | 5.11762814 |
3 | Dysostosis multiplex (HP:0000943) | 5.11080074 |
4 | Myositis (HP:0100614) | 4.98842116 |
5 | Retrobulbar optic neuritis (HP:0100654) | 4.93997707 |
6 | Optic neuritis (HP:0100653) | 4.93997707 |
7 | Vacuolated lymphocytes (HP:0001922) | 4.79727316 |
8 | Mucopolysacchariduria (HP:0008155) | 4.54810684 |
9 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.54810684 |
10 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.47778248 |
11 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.47778248 |
12 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.47778248 |
13 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.40759961 |
14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.40759961 |
15 | Abnormality of glycolipid metabolism (HP:0010969) | 4.40759961 |
16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.17956128 |
17 | Recurrent abscess formation (HP:0002722) | 4.10077660 |
18 | Mediastinal lymphadenopathy (HP:0100721) | 4.05743272 |
19 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.95175808 |
20 | Supranuclear gaze palsy (HP:0000605) | 3.85476997 |
21 | Neurofibrillary tangles (HP:0002185) | 3.85236894 |
22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.69352666 |
23 | Recurrent bacterial skin infections (HP:0005406) | 3.65307853 |
24 | Abnormality of macrophages (HP:0004311) | 3.56511029 |
25 | Keratoconjunctivitis sicca (HP:0001097) | 3.32508558 |
26 | Axonal loss (HP:0003447) | 3.32149741 |
27 | Loss of speech (HP:0002371) | 3.31565840 |
28 | Eczematoid dermatitis (HP:0000976) | 3.22484733 |
29 | Keratoconjunctivitis (HP:0001096) | 3.13163939 |
30 | Systemic lupus erythematosus (HP:0002725) | 3.12420550 |
31 | Gastrointestinal infarctions (HP:0005244) | 3.11338730 |
32 | Vasculitis (HP:0002633) | 3.06085284 |
33 | Cerebral inclusion bodies (HP:0100314) | 3.04396662 |
34 | Hemoptysis (HP:0002105) | 2.99919333 |
35 | Meningitis (HP:0001287) | 2.95820849 |
36 | Spontaneous hematomas (HP:0007420) | 2.95145173 |
37 | Autoimmune thrombocytopenia (HP:0001973) | 2.93429893 |
38 | Neuronal loss in central nervous system (HP:0002529) | 2.91790361 |
39 | Pulmonary infiltrates (HP:0002113) | 2.91718569 |
40 | Encephalitis (HP:0002383) | 2.81994751 |
41 | Gingivitis (HP:0000230) | 2.78564818 |
42 | Increased serum ferritin (HP:0003281) | 2.70314523 |
43 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.67991741 |
44 | Urticaria (HP:0001025) | 2.65846583 |
45 | Tetany (HP:0001281) | 2.64400085 |
46 | Episodic fever (HP:0001954) | 2.59324079 |
47 | Peripheral demyelination (HP:0011096) | 2.58995392 |
48 | Disinhibition (HP:0000734) | 2.58926174 |
49 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.53697907 |
50 | Recurrent cutaneous fungal infections (HP:0011370) | 2.53697907 |
51 | Petechiae (HP:0000967) | 2.47523721 |
52 | Increased IgE level (HP:0003212) | 2.47482639 |
53 | Retinal atrophy (HP:0001105) | 2.44148143 |
54 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.41724967 |
55 | Purpura (HP:0000979) | 2.39862342 |
56 | Increased circulating renin level (HP:0000848) | 2.39368304 |
57 | Leukocytosis (HP:0001974) | 2.35184978 |
58 | Arterial thrombosis (HP:0004420) | 2.34922878 |
59 | Hyperactive renin-angiotensin system (HP:0000841) | 2.33978962 |
60 | Gangrene (HP:0100758) | 2.31889445 |
61 | Anorexia (HP:0002039) | 2.29721041 |
62 | Global brain atrophy (HP:0002283) | 2.29469976 |
63 | Pulmonary embolism (HP:0002204) | 2.29302227 |
64 | Polyneuropathy (HP:0001271) | 2.26714268 |
65 | Asymmetric septal hypertrophy (HP:0001670) | 2.26264399 |
66 | Abnormality of iron homeostasis (HP:0011031) | 2.26035343 |
67 | Slow saccadic eye movements (HP:0000514) | 2.25722305 |
68 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.25603197 |
69 | Chest pain (HP:0100749) | 2.25515009 |
70 | Interstitial pulmonary disease (HP:0006530) | 2.25492472 |
71 | T lymphocytopenia (HP:0005403) | 2.24846359 |
72 | Abnormality of chloride homeostasis (HP:0011422) | 2.21947295 |
73 | Hypokalemic alkalosis (HP:0001949) | 2.21643104 |
74 | Metabolic alkalosis (HP:0200114) | 2.21295682 |
75 | Abnormality of renin-angiotensin system (HP:0000847) | 2.18370694 |
76 | Recurrent skin infections (HP:0001581) | 2.17906689 |
77 | Malnutrition (HP:0004395) | 2.17872413 |
78 | Increased IgM level (HP:0003496) | 2.17040809 |
79 | Increased CSF protein (HP:0002922) | 2.16261143 |
80 | Recurrent fungal infections (HP:0002841) | 2.15575142 |
81 | Colitis (HP:0002583) | 2.15448574 |
82 | Glomerulonephritis (HP:0000099) | 2.14294993 |
83 | Cellulitis (HP:0100658) | 2.11968883 |
84 | J-shaped sella turcica (HP:0002680) | 2.10264149 |
85 | Abnormality of T cell number (HP:0011839) | 2.10182157 |
86 | Vertigo (HP:0002321) | 2.08314912 |
87 | Abnormality of the pleura (HP:0002103) | 2.07884574 |
88 | Pustule (HP:0200039) | 2.05827322 |
89 | Decreased circulating renin level (HP:0003351) | 2.03784598 |
90 | Amyloidosis (HP:0011034) | 2.00857605 |
91 | Hypophosphatemia (HP:0002148) | 2.00812876 |
92 | Hepatosplenomegaly (HP:0001433) | 1.99644955 |
93 | Progressive visual loss (HP:0000529) | 1.98875716 |
94 | Recurrent viral infections (HP:0004429) | 1.98857703 |
95 | Inflammation of the large intestine (HP:0002037) | 1.98082343 |
96 | Acne (HP:0001061) | 1.97759696 |
97 | Prolonged bleeding time (HP:0003010) | 1.97533471 |
98 | Agnosia (HP:0010524) | 1.96509112 |
99 | Stomatitis (HP:0010280) | 1.96385218 |
100 | Mutism (HP:0002300) | 1.96357550 |
101 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94766363 |
102 | Diplopia (HP:0000651) | 1.94697555 |
103 | Abnormality of binocular vision (HP:0011514) | 1.94697555 |
104 | Abdominal distention (HP:0003270) | 1.93499519 |
105 | Memory impairment (HP:0002354) | 1.93470805 |
106 | Hydroxyprolinuria (HP:0003080) | 1.92399982 |
107 | Abnormality of proline metabolism (HP:0010907) | 1.92399982 |
108 | Myocardial infarction (HP:0001658) | 1.91919960 |
109 | Abnormality of the endocardium (HP:0004306) | 1.91687786 |
110 | Thyroiditis (HP:0100646) | 1.91296087 |
111 | Conjugated hyperbilirubinemia (HP:0002908) | 1.89206481 |
112 | Protuberant abdomen (HP:0001538) | 1.88736372 |
113 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.87845151 |
114 | Premature loss of primary teeth (HP:0006323) | 1.87388173 |
115 | Nuclear cataract (HP:0100018) | 1.87142537 |
116 | Apathy (HP:0000741) | 1.85923052 |
117 | Abnormality of the pericardium (HP:0001697) | 1.85365893 |
118 | Hematochezia (HP:0002573) | 1.84388879 |
119 | Epistaxis (HP:0000421) | 1.84238396 |
120 | Gastrointestinal inflammation (HP:0004386) | 1.82637986 |
121 | Thoracic kyphosis (HP:0002942) | 1.81907933 |
122 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.81853519 |
123 | Clumsiness (HP:0002312) | 1.81308527 |
124 | Progressive neurologic deterioration (HP:0002344) | 1.78870238 |
125 | Papilledema (HP:0001085) | 1.75769615 |
126 | Thick nail (HP:0001805) | 1.73844773 |
127 | Pathologic fracture (HP:0002756) | 1.72399486 |
128 | Onion bulb formation (HP:0003383) | 1.71859653 |
129 | Diminished motivation (HP:0000745) | 1.71777268 |
130 | Macroorchidism (HP:0000053) | 1.71279144 |
131 | Ovoid vertebral bodies (HP:0003300) | 1.69679209 |
132 | Psychosis (HP:0000709) | 1.69300993 |
133 | Chronic obstructive pulmonary disease (HP:0006510) | 1.68532186 |
134 | Obstructive lung disease (HP:0006536) | 1.68532186 |
135 | Abnormal urine output (HP:0012590) | 1.68116084 |
136 | Neurodegeneration (HP:0002180) | 1.67618997 |
137 | Chronic otitis media (HP:0000389) | 1.65729748 |
138 | Bone pain (HP:0002653) | 1.65206560 |
139 | Spastic tetraparesis (HP:0001285) | 1.62458165 |
140 | Dementia (HP:0000726) | 1.61653946 |
141 | Periodontitis (HP:0000704) | 1.61487191 |
142 | Frequent falls (HP:0002359) | 1.61418645 |
143 | Hypokalemia (HP:0002900) | 1.60695819 |
144 | Akinesia (HP:0002304) | 1.60513447 |
145 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.60095222 |
146 | Intention tremor (HP:0002080) | 1.59696944 |
147 | Coarse hair (HP:0002208) | 1.59445036 |
148 | Abnormality of renal excretion (HP:0011036) | 1.58512385 |
149 | Postural instability (HP:0002172) | 1.58438639 |
150 | Restrictive lung disease (HP:0002091) | 1.56764099 |
151 | Inappropriate behavior (HP:0000719) | 1.55806865 |
152 | Polydipsia (HP:0001959) | 1.55573157 |
153 | Abnormal drinking behavior (HP:0030082) | 1.55573157 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TAOK3 | 3.11958544 |
2 | RIPK4 | 2.93495615 |
3 | EPHB1 | 2.40271125 |
4 | CAMK1G | 2.23732840 |
5 | INSRR | 2.22736865 |
6 | MAP3K11 | 2.18743532 |
7 | MATK | 2.17151556 |
8 | ERN1 | 2.15105927 |
9 | MAP2K3 | 2.08973218 |
10 | RIPK1 | 2.00468190 |
11 | MAP3K2 | 1.98062304 |
12 | CAMK1D | 1.95468626 |
13 | IRAK3 | 1.94464380 |
14 | MAP3K3 | 1.84787942 |
15 | TAOK2 | 1.79675732 |
16 | PTK6 | 1.78952298 |
17 | TXK | 1.76916847 |
18 | FES | 1.75599480 |
19 | MAP4K1 | 1.74010555 |
20 | GRK7 | 1.73780318 |
21 | TYK2 | 1.63129947 |
22 | TNK2 | 1.61475421 |
23 | BLK | 1.51418004 |
24 | KIT | 1.49665166 |
25 | IRAK4 | 1.48003297 |
26 | MAP3K13 | 1.47227095 |
27 | SIK2 | 1.46785801 |
28 | WNK4 | 1.46601558 |
29 | TBK1 | 1.42420956 |
30 | JAK1 | 1.41130595 |
31 | OXSR1 | 1.39023779 |
32 | ACVR1B | 1.38118053 |
33 | FRK | 1.36781826 |
34 | MAP3K9 | 1.35749988 |
35 | HIPK2 | 1.34188576 |
36 | WNK1 | 1.34029750 |
37 | MAP3K14 | 1.30026657 |
38 | DDR2 | 1.29943934 |
39 | CAMKK2 | 1.27759137 |
40 | GRK6 | 1.27601277 |
41 | DAPK2 | 1.25538689 |
42 | PRKCH | 1.24813214 |
43 | MAP3K1 | 1.23388716 |
44 | NTRK1 | 1.23043235 |
45 | MAP3K10 | 1.22478265 |
46 | KSR2 | 1.18787716 |
47 | ITK | 1.17010955 |
48 | CDC42BPA | 1.16900062 |
49 | SIK3 | 1.15873001 |
50 | IRAK1 | 1.14982776 |
51 | HCK | 1.13531091 |
52 | SCYL2 | 1.13092020 |
53 | NME2 | 1.12550444 |
54 | ADRBK2 | 1.11290801 |
55 | IRAK2 | 1.09635909 |
56 | STK39 | 1.08156299 |
57 | FGR | 1.06576105 |
58 | MAPK15 | 1.03803536 |
59 | TGFBR2 | 1.03433444 |
60 | CSK | 1.02967608 |
61 | CSF1R | 1.02777766 |
62 | JAK2 | 1.00855365 |
63 | PDPK1 | 1.00146268 |
64 | IKBKE | 0.98396031 |
65 | SGK3 | 0.98324144 |
66 | BMPR2 | 0.97654348 |
67 | ZAP70 | 0.94823489 |
68 | CHUK | 0.94074064 |
69 | MARK3 | 0.91592880 |
70 | PDGFRB | 0.91213013 |
71 | TRIB3 | 0.90135567 |
72 | SYK | 0.89825632 |
73 | MARK2 | 0.89210874 |
74 | SGK494 | 0.88916813 |
75 | SGK223 | 0.88916813 |
76 | CAMKK1 | 0.86529282 |
77 | FYN | 0.84328487 |
78 | ICK | 0.83997612 |
79 | PTK2 | 0.81217401 |
80 | PDK1 | 0.80984800 |
81 | PRKD2 | 0.80331312 |
82 | LCK | 0.79580901 |
83 | PKN1 | 0.78391153 |
84 | MST4 | 0.76981068 |
85 | TESK2 | 0.74846534 |
86 | MAP2K6 | 0.73832860 |
87 | PAK6 | 0.72528843 |
88 | EPHA3 | 0.70174889 |
89 | RET | 0.70103107 |
90 | BTK | 0.68865538 |
91 | PRKD3 | 0.68076367 |
92 | PRKG2 | 0.67876190 |
93 | EGFR | 0.67547806 |
94 | LMTK2 | 0.67256757 |
95 | CLK1 | 0.67139932 |
96 | CDK12 | 0.67128212 |
97 | MET | 0.65982796 |
98 | MAP3K7 | 0.65203310 |
99 | MAP3K5 | 0.64028002 |
100 | PIM2 | 0.61432722 |
101 | MOS | 0.60042121 |
102 | CDK5 | 0.59680899 |
103 | RPS6KC1 | 0.59534063 |
104 | RPS6KL1 | 0.59534063 |
105 | PRKD1 | 0.59183318 |
106 | SIK1 | 0.58595262 |
107 | DYRK1B | 0.57199461 |
108 | RPS6KA6 | 0.56949894 |
109 | TYRO3 | 0.56710869 |
110 | FGFR3 | 0.54780302 |
111 | SGK2 | 0.54632024 |
112 | PRPF4B | 0.54475250 |
113 | TAOK1 | 0.50126583 |
114 | RPS6KA2 | 0.49239968 |
115 | MAPK12 | 0.48624911 |
116 | SGK1 | 0.48601991 |
117 | ABL2 | 0.47710012 |
118 | STK11 | 0.47700328 |
119 | PRKCQ | 0.46843344 |
120 | DMPK | 0.46622417 |
121 | MST1R | 0.45514791 |
122 | MAPK7 | 0.45436477 |
123 | LYN | 0.45242317 |
124 | MAP2K2 | 0.44840851 |
125 | SRC | 0.44784836 |
126 | GSK3A | 0.44219394 |
127 | STK10 | 0.43696642 |
128 | STK38 | 0.42677486 |
129 | ABL1 | 0.42270759 |
130 | JAK3 | 0.42258733 |
131 | PIM1 | 0.42025733 |
132 | WNK3 | 0.41582976 |
133 | YES1 | 0.41529645 |
134 | BRD4 | 0.41515321 |
135 | BMX | 0.41055959 |
136 | IKBKB | 0.40723465 |
137 | MAPK4 | 0.37380934 |
138 | MAP2K4 | 0.35627844 |
139 | PRKCZ | 0.33589579 |
140 | STK24 | 0.31576167 |
141 | KSR1 | 0.29557036 |
142 | PRKAA2 | 0.27413751 |
143 | PRKCD | 0.27175859 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.75305581 |
2 | Lysosome_Homo sapiens_hsa04142 | 2.69312680 |
3 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.35618054 |
4 | Allograft rejection_Homo sapiens_hsa05330 | 2.33767477 |
5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.28459642 |
6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.20743864 |
7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.10288148 |
8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.07291586 |
9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.02277875 |
10 | Mineral absorption_Homo sapiens_hsa04978 | 2.02037329 |
11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.96347124 |
12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.86863353 |
13 | Legionellosis_Homo sapiens_hsa05134 | 1.85956940 |
14 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.83281791 |
15 | Asthma_Homo sapiens_hsa05310 | 1.81539440 |
16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.80506369 |
17 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.71682085 |
18 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.55200635 |
19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.52849688 |
20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.47925000 |
21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.44286428 |
22 | Influenza A_Homo sapiens_hsa05164 | 1.43318688 |
23 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.41401720 |
24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.40968763 |
25 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.40764732 |
26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.37353962 |
27 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.31317059 |
28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.29743969 |
29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25929685 |
30 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.24971951 |
31 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.24724562 |
32 | Insulin secretion_Homo sapiens_hsa04911 | 1.23998767 |
33 | Measles_Homo sapiens_hsa05162 | 1.23962241 |
34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.23697465 |
35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.22686329 |
36 | Tuberculosis_Homo sapiens_hsa05152 | 1.20408401 |
37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19893493 |
38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.18276949 |
39 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.17361011 |
40 | Leishmaniasis_Homo sapiens_hsa05140 | 1.14562175 |
41 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.13758182 |
42 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.13526436 |
43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.11545476 |
44 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.10856086 |
45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.09644243 |
46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08302077 |
47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07750668 |
48 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.06501581 |
49 | Phagosome_Homo sapiens_hsa04145 | 1.06226693 |
50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.05790389 |
51 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.04798281 |
52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.02895211 |
53 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.01683441 |
54 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.01442413 |
55 | Pertussis_Homo sapiens_hsa05133 | 1.00623590 |
56 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.97829164 |
57 | ABC transporters_Homo sapiens_hsa02010 | 0.92809999 |
58 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.92693677 |
59 | Hepatitis B_Homo sapiens_hsa05161 | 0.91019612 |
60 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.89332442 |
61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89082294 |
62 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87910324 |
63 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.87798674 |
64 | Shigellosis_Homo sapiens_hsa05131 | 0.87391453 |
65 | Endocytosis_Homo sapiens_hsa04144 | 0.85952889 |
66 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.85255440 |
67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.84867242 |
68 | Bile secretion_Homo sapiens_hsa04976 | 0.84360137 |
69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.82514975 |
70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.81312156 |
71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81200383 |
72 | Renin secretion_Homo sapiens_hsa04924 | 0.80291512 |
73 | Salivary secretion_Homo sapiens_hsa04970 | 0.77819789 |
74 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75763218 |
75 | Salmonella infection_Homo sapiens_hsa05132 | 0.74678481 |
76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74556696 |
77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73645386 |
78 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.72651341 |
79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72341056 |
80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70884207 |
81 | Morphine addiction_Homo sapiens_hsa05032 | 0.70661455 |
82 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.69871954 |
83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69847368 |
84 | Prion diseases_Homo sapiens_hsa05020 | 0.69723925 |
85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69410497 |
86 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.69018487 |
87 | Bladder cancer_Homo sapiens_hsa05219 | 0.67298406 |
88 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67072708 |
89 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.66574045 |
90 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.64379177 |
91 | Insulin resistance_Homo sapiens_hsa04931 | 0.63930425 |
92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63649254 |
93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63133745 |
94 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62843145 |
95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61704981 |
96 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.60298739 |
97 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60164575 |
98 | Cocaine addiction_Homo sapiens_hsa05030 | 0.59809766 |
99 | Malaria_Homo sapiens_hsa05144 | 0.59430537 |
100 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.58886868 |
101 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58793656 |
102 | Olfactory transduction_Homo sapiens_hsa04740 | 0.57997085 |
103 | Circadian entrainment_Homo sapiens_hsa04713 | 0.57323158 |
104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56913163 |
105 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.56899278 |
106 | Hepatitis C_Homo sapiens_hsa05160 | 0.56430212 |
107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.55638829 |
108 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55378638 |
109 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55258649 |
110 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.55099789 |
111 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54966137 |
112 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52656286 |
113 | GABAergic synapse_Homo sapiens_hsa04727 | 0.52638444 |
114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52482663 |
115 | Long-term depression_Homo sapiens_hsa04730 | 0.50901835 |
116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50859344 |
117 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.50749192 |
118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50564488 |
119 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50444363 |
120 | Platelet activation_Homo sapiens_hsa04611 | 0.48925534 |
121 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48777247 |
122 | Histidine metabolism_Homo sapiens_hsa00340 | 0.48515086 |
123 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.48141649 |
124 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48071450 |
125 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47903534 |
126 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.47259136 |
127 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46833657 |
128 | Apoptosis_Homo sapiens_hsa04210 | 0.45650766 |
129 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.45623449 |
130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45366446 |
131 | Taste transduction_Homo sapiens_hsa04742 | 0.44788898 |
132 | Amoebiasis_Homo sapiens_hsa05146 | 0.44530529 |
133 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.43928277 |
134 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39134068 |
135 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37167680 |
136 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36042908 |
137 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.34770343 |
138 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29632549 |
139 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.28448294 |
140 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26000775 |
141 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.22974677 |
142 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22524586 |
143 | HTLV-I infection_Homo sapiens_hsa05166 | 0.20777611 |
144 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.20643112 |
145 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.20189619 |